MENU
CRVS
AS OF
Dec 26 closing price
Price
$7.70
Change
+$0.22 (+2.94%)
Capitalization
575.05M
67 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CRVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corvus Pharmaceuticals (CRVS) Ownership - Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
575.05M
P/E Ratio
N/A
Total Cash
65.69M
Projected Growth
N/A
Total Debt
1.01M
Revenue
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
0.88
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CRVS
Capitalization
575M
P/E Ratio
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
65.7M
Total Cash/Share
0.88
Total Debt
1.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
71.8M
P/B Ratio
8.01
Cash Flow
N/A
Earnings
-0.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
8.29
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-38.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.65
Shares Held By Institutions
431M
Shares Outstanding - Current
74.7M
Total Liabilities
8.71M
Total Volume MTD
N/A
Value
-1
Gain YTD
43.925
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRVS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRVS showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CRVS
A.I. Advisor
published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com